TR200400601T4 - Bir anti-tümöral etkiye sahip olan ikame edilmiş N-benzil-indol-3-il glioksilik asit türevleri - Google Patents

Bir anti-tümöral etkiye sahip olan ikame edilmiş N-benzil-indol-3-il glioksilik asit türevleri

Info

Publication number
TR200400601T4
TR200400601T4 TR2004/00601T TR200400601T TR200400601T4 TR 200400601 T4 TR200400601 T4 TR 200400601T4 TR 2004/00601 T TR2004/00601 T TR 2004/00601T TR 200400601 T TR200400601 T TR 200400601T TR 200400601 T4 TR200400601 T4 TR 200400601T4
Authority
TR
Turkey
Prior art keywords
compounds
indol
benzyl
substituted
acid derivatives
Prior art date
Application number
TR2004/00601T
Other languages
English (en)
Turkish (tr)
Inventor
G�Nther Eckhard
Emig Peter
Reichert Dietmar
Le Baut Guillaume
Nickel Bernd
Bacher Gerald
Original Assignee
Zentaris Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zentaris Gmbh filed Critical Zentaris Gmbh
Publication of TR200400601T4 publication Critical patent/TR200400601T4/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Indole Compounds (AREA)
TR2004/00601T 1999-12-23 2000-12-19 Bir anti-tümöral etkiye sahip olan ikame edilmiş N-benzil-indol-3-il glioksilik asit türevleri TR200400601T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19962300A DE19962300A1 (de) 1999-12-23 1999-12-23 Substituierte N-Benzyl-Indol-3-yl-glyoxylsäure-Derivate mit Antitumorwirkung

Publications (1)

Publication Number Publication Date
TR200400601T4 true TR200400601T4 (tr) 2004-04-21

Family

ID=7934006

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2004/00601T TR200400601T4 (tr) 1999-12-23 2000-12-19 Bir anti-tümöral etkiye sahip olan ikame edilmiş N-benzil-indol-3-il glioksilik asit türevleri

Country Status (31)

Country Link
US (1) US6432987B2 (cg-RX-API-DMAC7.html)
EP (1) EP1240157B1 (cg-RX-API-DMAC7.html)
JP (1) JP2003519137A (cg-RX-API-DMAC7.html)
KR (1) KR100747425B1 (cg-RX-API-DMAC7.html)
CN (1) CN1283637C (cg-RX-API-DMAC7.html)
AR (1) AR027098A1 (cg-RX-API-DMAC7.html)
AT (1) ATE259364T1 (cg-RX-API-DMAC7.html)
AU (1) AU772745B2 (cg-RX-API-DMAC7.html)
BG (1) BG106924A (cg-RX-API-DMAC7.html)
BR (1) BR0016712A (cg-RX-API-DMAC7.html)
CA (1) CA2395259A1 (cg-RX-API-DMAC7.html)
CO (1) CO5251472A1 (cg-RX-API-DMAC7.html)
CZ (1) CZ20022094A3 (cg-RX-API-DMAC7.html)
DE (2) DE19962300A1 (cg-RX-API-DMAC7.html)
DK (1) DK1240157T3 (cg-RX-API-DMAC7.html)
ES (1) ES2215768T3 (cg-RX-API-DMAC7.html)
HK (1) HK1054038B (cg-RX-API-DMAC7.html)
HU (1) HUP0203716A3 (cg-RX-API-DMAC7.html)
IL (1) IL150235A0 (cg-RX-API-DMAC7.html)
MX (1) MXPA02006229A (cg-RX-API-DMAC7.html)
NO (1) NO324750B1 (cg-RX-API-DMAC7.html)
NZ (2) NZ533731A (cg-RX-API-DMAC7.html)
PL (1) PL195014B1 (cg-RX-API-DMAC7.html)
PT (1) PT1240157E (cg-RX-API-DMAC7.html)
RU (1) RU2266280C2 (cg-RX-API-DMAC7.html)
SK (1) SK8752002A3 (cg-RX-API-DMAC7.html)
TR (1) TR200400601T4 (cg-RX-API-DMAC7.html)
TW (1) TWI284128B (cg-RX-API-DMAC7.html)
UA (1) UA75060C2 (cg-RX-API-DMAC7.html)
WO (1) WO2001047913A2 (cg-RX-API-DMAC7.html)
ZA (1) ZA200204896B (cg-RX-API-DMAC7.html)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19814838C2 (de) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
DE19946301A1 (de) * 1998-04-02 2001-04-19 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit therapeutisch wertvollen Eigenschaften
DE10037310A1 (de) * 2000-07-28 2002-02-07 Asta Medica Ag Neue Indolderivate und deren Verwendung als Arzneimittel
DE10318611A1 (de) * 2003-04-24 2004-11-11 Elbion Ag 4-, 6- oder 7-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
DE10318609A1 (de) * 2003-04-24 2004-11-11 Elbion Ag 5-Hydroxyindole mit N-Oxidgruppen und deren Verwendung als Therapeutika
JP4878285B2 (ja) * 2003-06-05 2012-02-15 エテルナ ツェンタリス ゲゼルシャフト ミット ベシュレンクテル ハフツング アポトーシス誘発作用を有するインドール誘導体
US7211588B2 (en) * 2003-07-25 2007-05-01 Zentaris Gmbh N-substituted indolyl-3-glyoxylamides, their use as medicaments and process for their preparation
SG146624A1 (en) 2003-09-11 2008-10-30 Kemia Inc Cytokine inhibitors
US7268159B2 (en) * 2003-09-25 2007-09-11 Wyeth Substituted indoles
DE102004031538A1 (de) * 2004-06-29 2006-02-09 Baxter International Inc., Deerfield Pharmazeutische Darreichungsform zur oralen Verabreichung eines schwerlöslichen Wirkstoffs, Verfahren zu deren Herstellung und Kit
US8604055B2 (en) 2004-12-31 2013-12-10 Dr. Reddy's Laboratories Ltd. Substituted benzylamino quinolines as cholesterol ester-transfer protein inhibitors
MX2007007919A (es) 2004-12-31 2008-01-22 Reddy Us Therapeutics Inc Nuevos derivados de bencilaminas como inhibidores de la proteina de transferencia de colesteril-ester(cetp).
JP5385605B2 (ja) * 2005-03-11 2014-01-08 バーテックス ファーマシューティカルズ インコーポレイテッド Atp結合カセットトランスポーターのモジュレーター
WO2008019357A2 (en) * 2006-08-07 2008-02-14 Ironwood Pharmaceuticals, Inc. Indole compounds
CA2670778A1 (en) * 2006-11-28 2008-06-05 Ziopharm Oncology, Inc. Use of indolyl-3-glyoxylic acid derivatives including indibulin, alone or in combination with further agents for treating cancer
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法
AR084433A1 (es) 2010-12-22 2013-05-15 Ironwood Pharmaceuticals Inc Inhibidores de la faah y composiciones farmaceuticas que los contienen
JP5964965B2 (ja) 2011-08-18 2016-08-03 ドクター レディズ ラボラトリーズ リミテッド コレステリルエステル転送タンパク質(cetp)インヒビターとしての置換複素環式アミン化合物
IN2014CN02290A (cg-RX-API-DMAC7.html) 2011-09-27 2015-06-19 Reddys Lab Ltd Dr

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1028812A (en) * 1962-08-28 1966-05-11 Ici Ltd Indole derivatives
WO1993023374A1 (fr) * 1992-05-08 1993-11-25 Otsuka Pharmaceutical Factory, Inc. Derive d'indole
IL109311A0 (en) * 1993-04-16 1994-07-31 Lilly Co Eli 1H-indole-3-acetamide sPla2 inhibitors
ES2122555T3 (es) * 1994-02-22 1998-12-16 Merrell Pharma Inc Nuevos derivados indolicos utiles para tratar neoplasmas y trastornos relacionados con estrogenos.
EP1950200B1 (en) * 1994-04-01 2012-01-11 Eli Lilly And Company [[3-(2-amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-11H-indol-4-yl]oxy]acetic acid methyl ester as sPLA2 inhibitor
DE19636150A1 (de) * 1996-09-06 1998-03-12 Asta Medica Ag N-substituierte Indol-3-glyoxylamide mit antiasthmatischer, antiallergischer und immunsuppressiver/immunmodulierender Wirkung
AU6229298A (en) * 1997-02-20 1998-09-09 Shionogi & Co., Ltd. Indole dicarboxylic acid derivatives
US5972988A (en) * 1997-03-26 1999-10-26 Eli Lilly And Company Method for treatment of chronic bronchitis using indole compounds
WO1998047507A1 (en) * 1997-04-24 1998-10-29 Shionogi & Co., Ltd. Method for the treatment of stroke using n-heterocyclic glyoxylamide compounds
TW455581B (en) * 1997-06-26 2001-09-21 Lilly Co Eli Process for preparing 4-substituted-1H-indole-3-glyoxamides
US6610728B2 (en) * 1997-08-28 2003-08-26 Eli Lilly And Company Method for treatment of non-rheumatoid arthritis
AU9664198A (en) * 1997-09-26 1999-04-23 Eli Lilly And Company Method for the treatment of cystic fibrosis
EP1030661A4 (en) * 1997-10-27 2002-07-17 Lilly Co Eli N, N-DIETHYLGLYCOLAMIDOESTER OF INDOLS AS PRELIMINARY MEDICINE OF SPLA 2 INHIBITORS
WO1999021545A1 (en) * 1997-10-27 1999-05-06 Eli Lilly And Company ISOPROPYL ESTER PRODRUGS OF INDOLE sPLA2 INHIBITORS
AU1200899A (en) * 1997-10-27 1999-05-17 Eli Lilly And Company Morpholino-n-ethyl ester prodrugs of indole spla2 inhibitors
WO1999024033A1 (en) * 1997-11-12 1999-05-20 Shionogi & Co., Ltd. Method for the treatment of disorders associated with apoptosis using n-heterocyclic glyoxylamide compounds
EP1039901A1 (en) * 1997-11-14 2000-10-04 Eli Lilly And Company Treatment for alzheimer's disease
GEP20032920B (en) * 1998-02-25 2003-03-25 Genetics Inst Inhibitors of Phospholipase Enzymes
DE19814838C2 (de) * 1998-04-02 2001-01-18 Asta Medica Ag Indolyl-3-glyoxylsäure-Derivate mit Antitumorwirkung
DZ2770A1 (fr) * 1998-04-17 2003-12-01 Lilly Co Eli Procédé de préparation de 1h-indol-3 glyoxamides substituées en position 4.
DE19818964A1 (de) * 1998-04-28 1999-11-04 Dresden Arzneimittel Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phospodiesterase 4 und Verfahren zu deren Herstellung
DK1076657T3 (da) * 1998-04-28 2004-11-08 Elbion Ag Hidtil ukendte hydroxyindoler, deres anvendelse som inhibitorer for phosphodiesterase 4 og fremgangsmåde til deres fremstilling
EA200001140A1 (ru) * 1998-05-01 2001-04-23 Эли Лилли Энд Компани СОЕДИНЕНИЯ-ИНГИБИТОРЫ sPLA2 ДЛЯ ЛЕЧЕНИЯ БОЛЕЗНИ
ID27812A (id) * 1998-05-01 2001-04-26 Lilly Co Eli ESTER PENGHAMBAT sPLA2
WO2000067802A1 (en) * 1999-05-10 2000-11-16 Protarga, Inc. Fatty acid-n-substituted indol-3-glyoxyl-amide compositions and uses thereof
TWI269654B (en) * 1999-09-28 2007-01-01 Baxter Healthcare Sa N-substituted indole-3-glyoxylamide compounds having anti-tumor action

Also Published As

Publication number Publication date
PT1240157E (pt) 2004-06-30
KR20020063245A (ko) 2002-08-01
RU2266280C2 (ru) 2005-12-20
CO5251472A1 (es) 2003-02-28
CA2395259A1 (en) 2001-07-05
NZ519977A (en) 2004-08-27
ZA200204896B (en) 2002-12-20
AR027098A1 (es) 2003-03-12
PL355684A1 (en) 2004-05-17
US6432987B2 (en) 2002-08-13
WO2001047913A2 (de) 2001-07-05
DE50005284D1 (de) 2004-03-18
IL150235A0 (en) 2002-12-01
PL195014B1 (pl) 2007-07-31
CN1420880A (zh) 2003-05-28
HUP0203716A3 (en) 2004-05-28
BG106924A (bg) 2003-04-30
AU772745B2 (en) 2004-05-06
AU2011901A (en) 2001-07-09
US20010014690A1 (en) 2001-08-16
UA75060C2 (en) 2006-03-15
CN1283637C (zh) 2006-11-08
TWI284128B (en) 2007-07-21
HK1054038B (zh) 2007-04-13
DK1240157T3 (da) 2004-06-14
WO2001047913A3 (de) 2002-04-25
EP1240157B1 (de) 2004-02-11
ES2215768T3 (es) 2004-10-16
NO324750B1 (no) 2007-12-03
RU2002120462A (ru) 2004-01-10
NO20023039D0 (no) 2002-06-21
DE19962300A1 (de) 2001-06-28
MXPA02006229A (es) 2003-01-28
SK8752002A3 (en) 2003-01-09
NO20023039L (no) 2002-08-09
BR0016712A (pt) 2002-09-03
HK1054038A1 (en) 2003-11-14
NZ533731A (en) 2005-03-24
EP1240157A2 (de) 2002-09-18
JP2003519137A (ja) 2003-06-17
ATE259364T1 (de) 2004-02-15
HUP0203716A2 (hu) 2003-03-28
KR100747425B1 (ko) 2007-08-09
CZ20022094A3 (cs) 2002-10-16

Similar Documents

Publication Publication Date Title
BR0014178A (pt) Derivados de ácido dicarboxìlico com propriedades farmacêuticas
TR200200649T2 (tr) Farmasötik özelliklere sahip olan yeni aminodikarboksilik asit türevleri
CU23208A3 (es) Oxazolidinonas sustituidas y su uso en el campo de la coagulacion sanguinea
TR200002761T2 (tr) HIV enfeksiyonlarının tedavisi için üç-ikameli 1,3,5-triazin türevleri.
BR0113643A (pt) Compostos de guanidinobenzamidas como agonistas de mc4-r e seus usos
CY1116103T1 (el) Υποκατεστημενα παραγωγα 1,2,3,4-τετραϋδροϊσοκινολινης
JO2282B1 (en) Oxazole derivatives
PT1147110E (pt) Derivados de pirazino (aza)-indol
IL127965A0 (en) Pentafluorobenzenesulfonamide derivatives analogs thereof and pharmaceutical compositions containing the same
TR200000223T2 (tr) XA faktörünü engelleyen heterosiklik türevler
ATE230610T1 (de) Hiv protease hemmer in pharmazeutischen zusammensetzungen zur behandlung von aids
WO2001047913A3 (de) Substituierte n-benzyl-indol-3-yl- glyoxylsäure-derivate antitumorwirkung
TR200001140T2 (tr) 6, 11-Köprülü eritromisin türevleri.
BR9910899A (pt) Compostos de ácido sulfÈnico ou sulfonilamino n-(hetero-aralquil)-azaeterocicliamida
PL360492A1 (en) Use of pamoic acid or one of its derivatives, or one of its analogues, for the preparation of a medicament for the treatment of diseases characterised by deposits of amyloid aggregates
ES2111352T3 (es) Uso de diester fosfato para el tratamiento de enfermedades retinianas.
BR9910628A (pt) Uso de um composto da série da benzofuroxana, composição farmacêutica, e, processos para a preparação de uma formulação parenteral e para o tratamento de um mamìfero, incluindo um ser humano, de doenças cardìacas da coronária
TR200200401T2 (tr) PEG-IFN-a ile birlikte mikofenolat mofetil
EE200200143A (et) 4-bensüülaminokinoliini konjugaadid sapphappega ja nende heteroanaloogid, nende valmistamismeetod ning neid ühendeid sisaldavad ravimid ja nende kasutamine
EP3802524A1 (en) Compounds for pain treatment, compositions comprising same, and methods of using same
DE69720966D1 (de) Benzo[c]chinolizin derivate,deren herstellung und verwendung als 5-alfa-reduktase inhibitoren
ATE284882T1 (de) Chromenylmethylpyrimidindiamine als antibakterielle wirkstoffe
AR033987A1 (es) Compuestos calcioliticos y su uso en la fabricacion de medicamentos
TR200200485T2 (tr) Yeni A-500359 türevleri.
PE20030236A1 (es) Derivados de bencimidazol 1-aril-2-n,s- u o-sustituidos, obtencion de medicamentos y preparados farmaceuticos que contienen estos derivados